Congratulations!!!! 💕

Kroonisen subduraalihematooman (KSDH) leikkaushoito yleistyy. KSDH:n leikkaus on neurokirurgian yleisin & yksinkertaisin toimenpide. Jo muinaisessa Egyptissä porattiin kalloihin reikiä, tosin huonommin tuloksin.😊 Tmp tehdään paikallispuudutuksessa. laakariportaali.fi/ammatti/uutise…

HUS Helsingin yliopistollinen sairaala Neurokirurgian klinikka maailmankuulu Ei kauan tällä menoa #hoitajapula romuttaa yhden terveydenhuollon kruununjalokivistämme ja potilaat kärsivät Samaan aikaan #Apotti:in tuhlataan satoja miljoonia! Herätys päätöksentekijät! @mediuutiset: mediuutiset.fi/uutiset/mu/071…

Pleased to share the final results of the FINISH trial published in The Lancet! Our findings support using subdural irrigation to reduce hematoma recurrence risk. A huge thank you to all collaborators and participants. Read more: authors.elsevier.com/a/1jDQ9_3CjG8u…

Kroonisen kovakalvonalaisen verenpurkauman kallonporausleikkauksessa tehtävä huuhtelu vähentää uusintaleikkauksia. Suomalaistutkimus yleisimmästä neurokirurgian päivystysleikkauksesta on julkaistu The Lancet -lehdessä. hus.fi/ajankohtaista/… #HUS Medicine and Health, University of Helsinki

Irrigation during craniotomy for chronic subdural hemorrhage reduces the need for repeat procedures. A Finnish study on the most common neurosurgical emergency procedure has been published in The Lancet. #HUS hus.fi/en/newsroom/he… Medicine and Health, University of Helsinki

Kroonisen kovakalvonalaisen verenpurkauman kallonporausleikkauksessa tehtävä huuhtelu vähentää uusintaleikkauksia, todettiin Lancetissa julkaistussa suomalaistutkimuksessa. #kallonporaus #tutkimus laakarilehti.fi/tieteessa/huuh…

New in The Lancet, results of the FINISH trial, a randomised non-inferiority trial of burr-hole drainage with or without irrigation for chronic subdural haematoma thelancet.com/journals/lance…

Night-time surgery for #CSDH shows no worse outcomes than daytime surgery—plus, fewer severe adverse events at night. Our findings challenge the traditional preference for daytime CSDH surgery. Read more in Acta Neurochirurgica: rdcu.be/dXMQi HUS Helsingin yliopistollinen sairaala Medicine and Health, University of Helsinki Rahul Raj

🩸Postoperative management of anticoagulated chronic subdural hematoma patients is complex, with 19% of patients experiencing thromboembolic or hemorrhagic complications, or vascular death within six months ⚠️ link.springer.com/10.1007/s00701… #HelsinkiNeurosurgery Pihla Tommiska Acta Neurochirurgica

After #CSDH surgery, thromboembolic events (8%) were slightly more common than hemorrhagic (6%) in patients on pre-op anticoagulation for #AF. Thromboembolic events severely worsened outcomes, emphasizing the need for prevention strategies. Acta Neurochirurgica link.springer.com/10.1007/s00701…

⏳🧠 Early surgery (≤22h) for chronic subdural hematoma was associated with significantly better functional outcomes compared to delays >22h. Time seems to matter—even in CSDH⏱️ sciencedirect.com/science/articl… World Neurosurgery Journal

🧠 Latest from the FINISH study group: 1 in 5 patients fails to improve functionally after burr-hole drainage. In patients with a pre-existing diagnosis of dementia, half fails to improve ⚠️ Importantly, reoperation for hematoma recurrence does not appear to influence functional

1/5 🚨 The RELACS Trial 🧠 The management of Chronic Subdural Hematoma (#CSDH) in patients with Atrial Fibrillation is a daily clinical dilemma. Approximately 20–25% of CSDH patients are on anticoagulants. Miikka Korja Teemu Luoto Teppo Järvinen HUS Helsingin yliopistollinen sairaala Medicine and Health, University of Helsinki

The RELACS protocol is out! No evidence-based guidelines exist on when to safely resume anticoagulation after #CSDH surgery in AF patients (≈20–25% of cases). RELACS compares early (5d) vs late (30d) restart to balance bleeding and thrombosis risks. 📄 rdcu.be/eQoTj

New post hoc analysis of the FINISH trial: Mortality & causes of death after #CSDH surgery (n=589). Key findings: 6-month mortality was 6.6%, increasing to 13.9% at ~16 months. Leading causes of death: Circulatory (34%), Accidents (16%), Dementia (15%). Mortality is strongly

After surgery for #CSDH, 14% of patients died during ~16 months follow-up. Top causes of death: • Circulatory diseases 34% • Accidents 16% • Dementia 15% Comorbidities, especially dementia, arrhythmias and prior stroke, were predictors of mortality. rdcu.be/eSI4n

New insights on #CSDH surgery: • Higher drainage volume → ↑ reoperations • Longer drainage time → ↓ reoperations • No link with 6-month outcomes CSDH drainage management may need more personalized strategies, not one standard drain time for all. journals.lww.com/neurosurgery/f…